Provided by Tiger Trade Technology Pte. Ltd.

Atrium Therapeutics

10.40
-0.1100-1.05%
Volume:200.92K
Turnover:2.11M
Market Cap:177.90M
PE:-2.70
High:10.74
Open:10.44
Low:10.31
Close:10.51
52wk High:16.77
52wk Low:10.31
Shares:17.11M
Float Shares:15.72M
Volume Ratio:0.95
T/O Rate:1.28%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.8578
EPS(LYR):-3.1905
ROE:-43.98%
ROA:-399.25%
PB:0.83
PE(LYR):-3.26

Loading ...

Atrium Therapeutics Q2 Basic EPS USD -1.18

THOMSON REUTERS
·
Aug 14

Atrium Therapeutics Posts Investor Presentation on Precision RNA Medicines for Cardiac Disease

Reuters
·
Aug 14

Atrium Therapeutics Posts Q2 R&D Expense of $15.3 Million on Trial Prep, IND-Enabling Work

Reuters
·
Aug 14

Atrium Therapeutics Q2 FY26 Net Loss Widens to $20.19 Million; Revenue Falls to $3 Million

Reuters
·
Aug 14

Atrium Therapeutics Q2 EPS $(1.18) Misses $(1.01) Estimate, Sales $3.004M Beat $2.000M Estimate

Benzinga Earnings
·
Aug 14

Atrium Therapeutics, Inc. (RNA) Receives a Buy from H.C. Wainwright

TIPRANKS
·
Aug 14

Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration

THOMSON REUTERS
·
Aug 13

Atrium Therapeutics - Eligible for up to $1.35 Bln R&D Milestones, $825 Mln Commercial Milestones, Tiered Royalties

THOMSON REUTERS
·
Aug 13

Atrium Therapeutics - Bristol Myers Squibb to Fund All Future Development and Commercialization Activities

THOMSON REUTERS
·
Aug 13

CSPC Pharma (01093) Receives FDA Clearance for US Clinical Trial of Monkeypox mRNA Vaccine

Stock News
·
Aug 10

HC Wainwright Initiates Atrium Therapeutics at Buy, With $25 Price Target

MT Newswires Live
·
Aug 06

U.S. Research Roundup-Caterpillar, Eli Lilly, McKesson

Reuters
·
Aug 06

Circio’s circVec gene therapy platform secures oral slot at top European ESGCT conference

TIPRANKS
·
Aug 06

Wave Life Sciences to Present at Upcoming Investor Conferences

GlobeNewswire
·
Aug 04

Circio Strengthens Board With RNA Therapy Veterans Ahead of Clinical Push

TIPRANKS
·
Aug 04

Noxopharm Data Validate TLR8-Targeted Oligonucleotide Cancer Strategy

TIPRANKS
·
Aug 04

Thalia Therapeutics Updates Voting Rights as RNA Therapy Pipeline Advances

TIPRANKS
·
Jul 31

Wave Life Sciences’ Earnings Call Highlights RNA Momentum

TIPRANKS
·
Jul 31

Wave Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update

GlobeNewswire
·
Jul 30

Wave Life Sciences Second Quarter 2026 Financial Results Scheduled for July 30, 2026

GlobeNewswire
·
Jul 23